{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:16:58Z","timestamp":1793575018401,"version":"4.5.0"},"reference-count":22,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.3899\/jrheum.2025-1181","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:20:15Z","timestamp":1765804815000},"page":"120-122","source":"Crossref","is-referenced-by-count":1,"title":["Changes in Modern Care for Juvenile Idiopathic Arthritis: How Much Does This Affect Health-Related Quality of Life?"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0264-0664","authenticated-orcid":false,"given":"Ruby J.","family":"Mckenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9441-5535","authenticated-orcid":false,"given":"Stephanie J.W.","family":"Shoop-Worrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026070105051062000_53.2.120.1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.43041","article-title":"Trends in new use of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis among commercially insured children in the United States from 2001 to 2022","volume":"77","author":"Yalamanchili","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"2026070105051062000_53.2.120.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213030"},{"key":"2026070105051062000_53.2.120.3","unstructured":"Multiple Sclerosis Trust . Disease modifying drugs (DMDs). [Internet. Accessed November 5, 2025.] Available from: https:\/\/mstrust.org.uk\/information-support\/ms-drugs-treatments\/disease-modifying-drugs-dmds"},{"key":"2026070105051062000_53.2.120.4","doi-asserted-by":"publisher","DOI":"10.1177\/15563316241247828"},{"key":"2026070105051062000_53.2.120.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0377"},{"key":"2026070105051062000_53.2.120.6","doi-asserted-by":"crossref","first-page":"SI173","DOI":"10.1093\/rheumatology\/kead560","article-title":"A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry","volume":"63","author":"Nguyen","year":"2024","journal-title":"Rheumatol"},{"key":"2026070105051062000_53.2.120.7","first-page":"738","article-title":"The Juvenile Arthritis Quality of Life Questionnaire\u2014development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides","volume":"24","author":"Duffy","year":"1997","journal-title":"J Rheumatol"},{"key":"2026070105051062000_53.2.120.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210511"},{"key":"2026070105051062000_53.2.120.9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/keac312","article-title":"Is time a healer? How quality of life changes over time reported by parents of children and young people with juvenile idiopathic arthritis","volume":"62","author":"Smith","year":"2023","journal-title":"Rheumatology"},{"key":"2026070105051062000_53.2.120.10","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/S2665-9913(20)30269-1","article-title":"Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study","volume":"3","author":"Shoop-Worrall","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2026070105051062000_53.2.120.11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel201"},{"key":"2026070105051062000_53.2.120.12","doi-asserted-by":"crossref","first-page":"104946","DOI":"10.1016\/j.ebiom.2023.104946","article-title":"Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts","volume":"100","author":"Shoop-Worrall","year":"2024","journal-title":"EBiomedicine"},{"key":"2026070105051062000_53.2.120.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.2505"},{"key":"2026070105051062000_53.2.120.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep460"},{"key":"2026070105051062000_53.2.120.15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/acr.24839","article-title":"American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging","volume":"74","author":"Onel","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2026070105051062000_53.2.120.16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43166-022-00125-1","article-title":"Updated clinical practice treat-to-target guidelines for JIA management: the Egyptian College of Pediatric Rheumatology initiative","volume":"49","author":"El Miedany","year":"2022","journal-title":"Egypt Rheumatol Rehabil"},{"key":"2026070105051062000_53.2.120.17","doi-asserted-by":"crossref","first-page":"109143","DOI":"10.1016\/j.clim.2022.109143","article-title":"Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): new perspectives on interdisciplinary care","volume":"245","author":"Oommen","year":"2022","journal-title":"Clin Immunol"},{"key":"2026070105051062000_53.2.120.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210112"},{"key":"2026070105051062000_53.2.120.19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-018-0226-0","article-title":"Patient\u2019s experiences with the care for juvenile idiopathic arthritis across Europe","volume":"16","author":"van Dijkhuizen","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026070105051062000_53.2.120.20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/healthcare11050749","article-title":"Socioeconomic status and quality of life: an assessment of the mediating effect of social capital","volume":"11","author":"Nutakor","year":"2023","journal-title":"Healthcare"},{"key":"2026070105051062000_53.2.120.21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/acr.22466","article-title":"The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the childhood arthritis prospective study","volume":"67","author":"Verstappen","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2026070105051062000_53.2.120.22","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22117"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-1181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:12:23Z","timestamp":1782907943000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-1181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,1]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.3899\/jrheum.2025-1181"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-1181","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}